Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer

BACKGROUND: Small cell lung cancer (SCLC) is an aggressive malignancy. Surgical resection is currently only recommended for clinical stage I patients who have been carefully staged. The clinical outcomes of patients with resected SCLCs vary because the disease is highly heterogeneous, suggesting tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yina, Dong, Yangyang, Zhou, Yingxu, Chen, Gongyan, Hong, Xuan, Zhang, Qingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718634/
https://www.ncbi.nlm.nih.gov/pubmed/36605462
http://dx.doi.org/10.1155/2022/4183326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718634/
https://www.ncbi.nlm.nih.gov/pubmed/36605462
http://dx.doi.org/10.1155/2022/4183326

Ejemplares similares